Gary Andrew Rhodes
Gary Andrew Rhodes is a British health technology entrepreneur and founder of Screen My Bones®, a global initiative promoting early bone health screening. He is also a partner and Global Director at Performance Health Systems, the company behind Power Plate® and Biodensity, two technologies widely used in musculoskeletal health and rehabilitation. Rhodes is recognized for his work in developing scalable, technology-enabled solutions for bone and muscle health optimisation.
Early Career and Background
Rhodes has worked in the health and wellness sector for over 25 years, with a focus on health optimisation, brain-body connection, and performance enhancement. He has been involved in multiple startups and successful business exits prior to focusing on musculoskeletal health.
His interest in bone health intensified following a personal experience: after his grandmother was diagnosed with osteoporosis, Rhodes began researching solutions beyond conventional care. Dissatisfied with the prevailing narrative that bone loss is inevitable with age, he pursued scientific avenues that ultimately reversed her condition through mechanical loading and non-invasive diagnostics.
Screen My Bones®
Rhodes founded Screen My Bones® as a proactive screening platform designed to detect early signs of osteoporosis and skeletal weakening. The initiative centres on Echolight REMS (Radiofrequency Echographic Multi Spectrometry), a non-invasive, radiation-free technology that assesses both bone density and quality. The platform is intended to make bone health diagnostics more accessible, especially to younger individuals typically excluded from traditional screening recommendations.
Screen My Bones operates in multiple locations across the United Kingdom and is expanding globally through clinical partnerships and public health initiatives.
Performance Health Systems
In addition to founding Screen My Bones, Rhodes serves as Global Director at Performance Health Systems, a medical technology company known for Power Plate®, a whole-body vibration training platform, and Biodensity, a device that uses osteogenic loading to stimulate bone growth. Rhodes helped establish the company’s musculoskeletal division, Performance Health Systems MSK, which focuses on integrating evidence-based technology into clinical, wellness, and rehabilitation settings.
Health Philosophy
Rhodes is an advocate for redefining osteoporosis not as a disease but as a deconditioning of the bone—a state that, like muscle, can be reconditioned through proper intervention. He promotes the concept that musculoskeletal health is a primary biomarker of longevity and should be proactively addressed decades before fractures or degenerative complications occur.
Collaborations and Public Engagement
Rhodes works alongside internationally recognised experts in orthopaedics, regenerative medicine, and longevity science. His initiatives are focused on aligning innovation with practical implementation in clinics, corporate wellness programs, and public health policy.
He frequently speaks at conferences, longevity forums, and health summits, addressing topics such as non-invasive diagnostics in bone health, osteogenic loading, muscle and bone longevity markers, and preventive health screening.
Media and Public Statements
In public interviews, Rhodes has stated:
“Bone health is the foundation of longevity. At Screen My Bones, we’re not just screening—we’re setting a new global standard for prevention, giving people the power to strengthen their future before fractures define it.”
See Also
- Osteoporosis
- Bone Density Scanning
- Echolight REMS
- Power Plate
- Osteogenic Loading
- Musculoskeletal Health
- Preventive Health Screening